Adverse Reactions Toxicology Diltiazem Calcium Channel Blockers Drug Interactions Thyroid Medication Potassium Competitive Acid Blockers Ozempic Diabetes Drugs Blood Thinners Blood Cancers Pharmacy Benefit Managers Type 2 Diabetes Doliprane
Sanofi retains a 48.2% stake as Doliprane, France’s top-prescribed drug, transitions to shared ownership with CD&R and Bpifrance to fund innovation and shareholder returns.